Clinical Trial Update: Levo Phencynonate Hydrochloride for the Prevention of Seasickness [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Levo Phencynonate Hydrochloride for the prevention of seasickness has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Drugs mentioned

• Levo Phencynonate Hydrochloride

Snippet

Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Motion Sickness | Phase 2 | Status: COMPLETED